Candel Therapeutics, Inc. CADL Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Candel Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The official record: Candel Therapeutics, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Candel Therapeutics, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Candel Therapeutics, Inc.'s operating lease ROU assets?
- Candel Therapeutics, Inc. (CADL) reported operating lease ROU assets of $1.57M in Q1 2026.
- How has Candel Therapeutics, Inc.'s operating lease ROU assets changed year-over-year?
- Candel Therapeutics, Inc.'s operating lease ROU assets increased by 235.3% year-over-year, from $468K to $1.57M.
- What is the long-term trend for Candel Therapeutics, Inc.'s operating lease ROU assets?
- Over 3 years (2022 to 2025), Candel Therapeutics, Inc.'s operating lease ROU assets has grown at a 16.3% compound annual growth rate (CAGR), from $1.06M to $1.66M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.